Inflammasome Therapeutics ( a clinical-stage biotech company developing a new class of drugs, Kamuvudines, for ophthalmic and neurological conditions, announced the company has signed a contract with ...
In January, AbbVie and Calico’s fosigotifator failed to show significant signs of efficacy in the HEALEY ALS platform trial ...
Todd Adams, chairman and CEO of Adams Bank and Trust, which has several branches in the Boulder Valley and Northern Colorado, ...
Diagnosed with A.L.S., they traded stories, drank tequila and made grim jokes at a unique annual gathering on Cape Cod.
The ALS prevalence is expected to rise across multiple nations by 2040 due to aging populations and increased ALS survival ...
Although amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). are very different diseases, they have ...
Researchers in Germany say combining two blood biomarkers may make the diagnosis of ALS more accurate and help predict ...
Sundin, who received the award on Saturday afternoon in a Swedish hockey star-studded ballroom at the Grand Hotel in ...
A drug candidate found to protect nerve cells damaged by motor neuron disease (MND), could offer new hope to people living ...
Sandra Bullock broke cover for the first time in almost a year on Wednesday while driving around Los Angeles The actress, 61, ...
Researchers at Tel Aviv University say they have identified a molecular switch in amyotrophic lateral sclerosis (ALS) and ...
Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback